A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.
Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE.
Sigal LH, et al. Among authors: sabetta jr.
N Engl J Med. 1998 Jul 23;339(4):216-22. doi: 10.1056/NEJM199807233390402.
N Engl J Med. 1998.
PMID: 9673299
Free article.
Clinical Trial.